Business
Why the ResApp (ASX:RAP) share price is climbing higher
The ResApp Health Ltd (ASX: RAP) share price is climbing higher today. This comes after the company provided an update of its prescription-only software application with the United States Food and Drug Administration (FDA).
At the time of writing, shares in the digital health company are trading 1.4% higher at 6.8 cents.
What did ResApp announce?
In today’s release, ResApp advised it has sent a pre-submission package to the FDA for clearance on its smartphone-based medical software application. The company also requested a meeting with the FDA to discuss how to obtain regulatory approval and any other requirements.
ResApp’s latest software application uses machine-learning algorithms to detect cough sounds recorded by a…
-
Noosa News22 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News23 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General21 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
General21 hours agoTruck driver charged with causing death by dangerous driving after highway crash